Acrocinonide
Clinical data | |
---|---|
Other names | Triamcinolone acroleinide; Triamcinolone 16,17-2-propenal acetal; SD 2102-18; 9α-Fluoro-11β,21-dihydroxy-16α,17α-(2-propenylidenedioxy)pregna-1,4-dien-3,20-dione; 9α-Fluoro-11β,16α,17α,21-tetrahydroxypregna-1,4-diene-3,20-dione cyclic 16,17-acetal with acrolein |
Drug class | Corticosteroid; Glucocorticoid |
Identifiers | |
IUPAC name
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
ChEMBL | |
CompTox Dashboard (EPA) | |
Chemical and physical data | |
Formula | C24H29FO6 |
Molar mass | 432.488 g·mol−1 |
3D model (JSmol) | |
SMILES
| |
InChI
|
Acrocinonide (developmental code name SD 2102-18; also known as triamcinolone acroleinide) is a synthetic glucocorticoid corticosteroid which was never marketed.[1]
References
- ↑ Elks J (14 November 2014). The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and Bibliographies. Springer. pp. 1228–. ISBN 978-1-4757-2085-3.
This article is issued from Offline. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.